Gene therapy strategies for multiple sclerosis
The Nervous System Gene Therapy (UAB) research group and the VHIR Multiple Sclerosis Center of Catalonia are developing a gene therapy capable of reducing the inflammatory response in early and advanced stages of the disease. The results obtained in animal models are...
